| Prion detection by an amyloid seeding assay DW Colby, Q Zhang, S Wang, D Groth, G Legname, D Riesner, ... Proceedings of the National Academy of Sciences 104 (52), 20914-20919, 2007 | 273 | 2007 |
| Neuroprotective Sirtuin ratio reversed by ApoE4 V Theendakara, A Patent, CA Peters Libeu, B Philpot, S Flores, ... Proceedings of the National Academy of Sciences 110 (45), 18303-18308, 2013 | 110 | 2013 |
| Coronavirus disease 2019 case fatality and Parkinson's disease Q Zhang, JL Schultz, GM Aldridge, JE Simmering, NS Narayanan Movement disorders 35 (11), 1914, 2020 | 69 | 2020 |
| Approach to cognitive impairment in Parkinson's disease Q Zhang, GM Aldridge, NS Narayanan, SW Anderson, EY Uc Neurotherapeutics 17 (4), 1495-1510, 2020 | 48 | 2020 |
| Four decades of research in Alzheimer’s disease (1975–2014): a bibliometric and scientometric analysis A Serrano-Pozo, GM Aldridge, Q Zhang Journal of Alzheimer's disease 59 (2), 763-783, 2017 | 46 | 2017 |
| Novel mediators of amyloid precursor protein signaling A Swistowski, Q Zhang, ME Orcholski, D Crippen, C Vitelli, A Kurakin, ... Journal of Neuroscience 29 (50), 15703-15712, 2009 | 45 | 2009 |
| Signaling via amyloid precursor-like proteins APLP1 and APLP2 ME Orcholski, Q Zhang, DE Bredesen Journal of Alzheimer's disease 23 (4), 689-699, 2011 | 34 | 2011 |
| Modeling and design of phytoremediation LC Davis, LE Erickson, M Narayanan, Q Zhang Phytoremediation: Transformation and control of contaminants, 661-694, 2003 | 31 | 2003 |
| Disease-modifying therapeutic directions for Lewy-Body dementias Q Zhang, YC Kim, NS Narayanan Frontiers in Neuroscience 9, 293, 2015 | 30 | 2015 |
| AβPP-selective BACE inhibitors (ASBI): novel class of therapeutic agents for alzheimer's disease O Descamps, P Spilman, Q Zhang, CP Libeu, K Poksay, O Gorostiza, ... Journal of Alzheimer's disease 37 (2), 343-355, 2013 | 28 | 2013 |
| Paradoxical effect of TrkA inhibition in Alzheimer's disease models Q Zhang, O Descamps, MJ Hart, KS Poksay, P Spilman, DJ Kane, ... Journal of Alzheimer's disease 40 (3), 605-617, 2014 | 22 | 2014 |
| COVID-19 case fatality and Alzheimer’s disease Q Zhang, JL Schultz, GM Aldridge, JE Simmering, Y Kim, AC Ogilvie, ... Journal of Alzheimer's disease 84 (4), 1447-1452, 2021 | 21 | 2021 |
| Altering APP proteolysis: increasing sAPPalpha production by targeting dimerization of the APP ectodomain CAP Libeu, O Descamps, Q Zhang, V John, DE Bredesen PLoS one 7 (6), e40027, 2012 | 21 | 2012 |
| Alzheimer’s model develops early ADHD syndrome Q Zhang, G Du, V John, P Kapahi, DE Bredesen Journal of neurology & neurophysiology 6 (6), 1, 2015 | 17 | 2015 |
| Scopolamine and medial frontal stimulus-processing during interval timing Q Zhang, D Jung, T Larson, Y Kim, NS Narayanan Neuroscience 414, 219-227, 2019 | 10 | 2019 |
| Glycolysis-enhancing α1-adrenergic antagonists modify cognitive symptoms related to Parkinson’s disease MA Weber, K Sivakumar, EE Tabakovic, M Oya, GM Aldridge, Q Zhang, ... npj Parkinson's Disease 9 (1), 32, 2023 | 9 | 2023 |
| Medial prefrontal cortex and the temporal control of action Q Zhang, MA Weber, NS Narayanan International review of neurobiology 158, 421-441, 2021 | 9 | 2021 |
| Induction of the C-terminal proteolytic cleavage of AβPP by statins O Descamps, Q Zhang, V John, DE Bredesen Journal of Alzheimer's disease 25 (1), 51-57, 2011 | 9 | 2011 |
| Mice expressing P301S mutant human tau have deficits in interval timing T Larson, V Khandelwal, MA Weber, MR Leidinger, DK Meyerholz, ... Behavioural brain research 432, 113967, 2022 | 7 | 2022 |
| Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice Q Zhang, H Abdelmotilib, T Larson, C Keomanivong, M Conlon, ... Neuroscience letters 765, 136273, 2021 | 5 | 2021 |
Nandakumar NarayananJuanita J. Bartlett Associate Professor of Neurology & Associate Director, Iowa NeuroscienceEmail yang diverifikasi di uiowa.edu
